Esophagogastric Cancer
📧 Sign up to get email alerts when something new happens for Esophagogastric Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-03-23Clinical Trial Update: A Study of Tooth Erosion in People With Esophagogastric Cancer [NA]
This clinical trial update describes a study evaluating tooth erosion in people with esophagogastric cancer (NCT05612048). The trial status …
-
CLINICAL_TRIALS research · 2026-03-11Clinical Trial Update: HEARTS Trial for Thoracic Cancers [Phase 2]
HEARTS is a Phase 2 clinical trial targeting thoracic cancers, including non-small cell lung cancer, esophageal cancer, esophagogastric canc…
-
CLINICAL_TRIALS research · 2026-03-05Clinical Trial Update: PET-MRI Esophagus Feasibility Study [NA]
A feasibility study evaluating PET-MRI imaging for esophagogastric cancer is currently recruiting. No results are reported yet.
-
CLINICAL_TRIALS trial_result · 2026-03-04Clinical Trial Update: A Study of Nivolumab Combined With FOLFOX and Regorafenib in People Who Have HER2-Negative Esophagogastric Cancer [Phase 2]
Phase 2 trial evaluating a combination of nivolumab with FOLFOX and regorafenib in HER2-negative esophagogastric cancer; the study is curren…
-
CLINICAL_TRIALS trial_result · 2026-02-17Clinical Trial Update: A Study of Amivantamab in People With Esophagogastric Cancer [Phase 2]
Phase 2 clinical trial update for amivantamab in esophagogastric cancer; the study is currently active and not recruiting.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-01-06Clinical Trial Update: A Study of Safety and Efficacy of KFA115 Alone and in Combo With Pembrolizumab in Patients With Select Advanced Cancers [Phase 1]
Phase 1 study assessing safety and early efficacy of KFA115 alone and in combination with pembrolizumab in select advanced cancers; the tria…
-
CLINICAL_TRIALS research · 2025-12-22Clinical Trial Update: REACTION (Radiation Enhanced Assessment of Combination Therapies in Immuno-ONcology) - Nivolumab or Nivolumab in Combination With Other Immuno-oncology (IO) Agents After Targeted Systemic Radiation in Patients With Advanced Esophagogastric Cancer [Phase 1, Phase 2]
This entry covers the REACTION trial (NCT03610711) evaluating nivolumab, alone or with other immune checkpoint inhibitors, after targeted sy…
-
CLINICAL_TRIALS research · 2025-11-14Clinical Trial Update: Folfox+Irinotecan+Chemort In Esophageal Cancer [Phase 2]
Phase 2 clinical trial evaluating a FOLFOX plus Irinotecan regimen with chemotherapy for gastroesophageal junction adenocarcinoma and esopha…
-
CLINICAL_TRIALS trial_result · 2025-03-05Clinical Trial Update: PHASE III RANDOMISED TRIAL to EVALUATE FOLFOX with or WITHOUT DOCETAXEL (TFOX) AS 1st LINE CHEMOTHERAPY for LOCALLY ADVANCED or METASTATIC OESOPHAGO-GASTRIC CARCINOMA [Phase 3]
A Phase III randomized trial evaluating FOLFOX with or without docetaxel as first-line chemotherapy for locally advanced or metastatic esoph…
-
CLINICAL_TRIALS trial_result · 2024-12-10Clinical Trial Update: PET Imaging With 89Zr-DFO-Trastuzumab in Esophagogastric Cancer [NA]
Completed clinical trial evaluating PET imaging with 89Zr-DFO-Trastuzumab in esophagogastric cancer; results posted.
-
CLINICAL_TRIALS trial_result · 2023-11-02Clinical Trial Update: STA-9090 in Previously Treated Patients With Advanced Esophagogastric Cancer [Phase 2]
Phase 2 trial update for STA-9090 in patients with advanced esophagogastric cancer has completed.
-
CLINICAL_TRIALS trial_result · 2023-02-01Clinical Trial Update: A Single-Arm Pilot Study of Adjuvant Pembrolizumab Plus Trastuzumab in HER2+ Esophagogastric Tumors With Persistent Circulating Tumor DNA Following Curative Resection [Phase 2]
Phase 2 single-arm pilot studying adjuvant pembrolizumab plus trastuzumab in HER2-positive esophagogastric tumors with persistent circulatin…
-
CLINICAL_TRIALS trial_result · 2021-01-25Clinical Trial Update: Nintedanib in Patients With Advanced Esophagogastric Cancer [Phase 2]
Phase 2 trial update of nintedanib in advanced esophagogastric cancer.
-
CLINICAL_TRIALS trial_result · 2020-05-04Clinical Trial Update: Study to Evaluate the Safety and Tolerability of Andecaliximab as Monotherapy and in Combination With Chemotherapy in Participants With Advanced Solid Tumors [Phase 1]
Phase 1 trial evaluating safety and tolerability of Andecaliximab as monotherapy and in combination with chemotherapy in advanced solid tumo…
-
CLINICAL_TRIALS trial_result · 2019-09-18Clinical Trial Update: Proof-of-concept Study of Ibrutinib in c-MYC and HER2 Amplified Oesophagogastric Carcinoma [Phase 2]
Phase 2 proof-of-concept trial evaluating ibrutinib in c-MYC and HER2 amplified oesophagogastric carcinoma (gastroesophageal cancer).
-
CLINICAL_TRIALS research · 2016-12-01Clinical Trial Update: Chemotherapy With or Without Bevacizumab or Lapatinib to Treat Operable Oesophagogastric Cancer [Phase 2, Phase 3]
An update on a Phase 2/3 trial evaluating whether adding bevacizumab or lapatinib to chemotherapy improves outcomes in operable esophagogast…
-
CLINICAL_TRIALS research · 2016-11-01Clinical Trial Update: Does Prehabilitation Improve Exercise Performance and Insulin Resistance After Surgery for Oesophago-gastric Cancer? [NA]
This document notes a clinical trial evaluating whether a prehabilitation program improves exercise performance and insulin resistance after…
-
CLINICAL_TRIALS trial_result · 2012-12-11Clinical Trial Update: REAL3 Trial of Efficacy of EOX With/Without Panitumumab in Previously Untreated Adv OG Cancer [Phase 3]
The REAL3 Phase 3 trial evaluating EOX with or without panitumumab for previously untreated advanced esophagogastric cancer was terminated.